Skip to content

Posts by Former NIMH Director Thomas Insel from 2012

Autism Progress

By Thomas Insel on

Dr. Insel highlights key recent findings in research on autism spectrum disorders.

Read More

The Top Ten Research Advances of 2012

By Thomas Insel on

Dr. Insel describes his top picks in research advances for 2012.

Read More

Roads Not Taken

By Thomas Insel on

NIMH’s director talks about the need for research that explores the frontiers of science and funding efforts to encourage innovative research.

Read More

From Practice to Research

By Thomas Insel on

Dr. Insel introduces an innovative approach that one group is taking to speed up the dissemination of research results into clinical practice.

Read More

A Decade of Perspective

By Thomas Insel on

In looking back at ten years as NIMH director, Dr. Insel talks about the importance of rigorous science as the source of new, sometimes surprising, knowledge and ultimately, more effective means of prevention and treatment for mental illness.

Read More

Words Matter

By Thomas Insel on

Some barriers to progress are simply linguistic. In mental health, we are stymied by our language. For example, terms like “depression” or “schizophrenia” or “autism” have achieved a reality that far outstrips their scientific value. Each refers to a cluster of symptoms, similar to “fever” or “headache.” Yet the field has imbued these “fictive categories” with biological meaning, which has precluded the development of biomarkers that might confer validity. Is PTSD – or autism – a “disorder” or an injury? We need a broad conversation to help us understand how our language may be holding us back, limiting not only our impact but our imagination.

Read More

Junk No More

By Thomas Insel on

If genes comprise only 2 percent of our DNA, what is the function of the remaining 98 percent?  A massive ENCODE project has revealed that nearly 80 percent of our genome is read out, or transcribed – much of it devoted to regulating the turning on and off of genes.  Yet, there are also vast stretches of non-coding RNAs, some unique to humans, especially regions that appear active for specifying brain development.  Differences associated with autism and mental disorders are in these areas previously considered “junk.” The new map pinpoints sites where proteins called transcription factors alter the timing and amounts of gene expression – mechanisms that are likely at the heart of mental disorders, whether they are mainly due to environmental stressors or genetic factors.

Read More

Strategy on Suicide Prevention

By Thomas Insel on

Dr. Insel provides context for a new National Strategy for Suicide Prevention

Read More

Summer Science

By Thomas Insel on

Numerous provocative advances in neuroscience were reported during the summer of 2012.

Read More

A Promising Behavioral Treatment for Tourette Syndrome

By Thomas Insel on

Dr. Insel describes a new behavioral treatment for a neurologically based disorder that has traditionally been difficult to treat. 

Read More

Preventing Suicide, One Employer at a Time

By Thomas Insel on

Dr. Insel discusses recent efforts made by the NFL and other employers to help prevent suicides, and the importance of suicide prevention research.

Read More

Achieving an AIDS-free Generation

By Thomas Insel on

NIMH research on HIV/AIDS will be well represented at the XIX International AIDS Conference, being held in the United States for the first time since 1990.

Read More

The Pay-Offs of ARRA

By Thomas Insel on

Read More

Experimental Medicine

By Thomas Insel on

Dr. Insel discusses the crisis of medication development for mental disorders.

Read More

Serving Those Who Served

By Thomas Insel on

Serving Those Who Served

Read More

Time Matters – Why We Care So Much About Data Sharing

By Thomas Insel on

Dr. Insel discusses the dynamics of data sharing in research.

Read More

Citizen Science

By Thomas Insel on

Presentations at a recent meeting in San Diego showed how new technologies are being used to change the culture of science, empowering patients, and fueling innovative research approaches.

Read More

The Future of Psychiatry (= Clinical Neuroscience)

By Thomas Insel on

While fewer medical students are choosing psychiatry in the U.K., in the U.S. psychiatry is attracting increasing numbers of elite MD-PhD students who want to do research. These young scientists are committed to developing a new scientific basis for clinical care.

Read More

The New Genetics of Autism – Why Environment Matters

By Thomas Insel on

Dr. Insel discusses how new research may help tie together seemingly disparate findings in genetic vs environmental risk factors in autism spectrum disorders.

Read More

Brain’s Wiring Revealed in HD

By Thomas Insel on

Dr. Insel discusses new functional connectomes and developments in human brain imaging.

Read More

Autism Prevalence: More Affected or More Detected?

By Thomas Insel on

Dr. Insel discusses the CDC's latest report on autism prevalence.

Read More

From Paresis to PANDAS and PANS

By Thomas Insel on

Dr. Insel discusses the connection between mental disorders and infection in light of pediatric neuropsychiatric disorders PANS and PANDAS.

Read More

Join the Revolution

By Thomas Insel on

Dr. Insel discusses the state of science and math education in the U.S., scientific literacy, and Brain Awareness Week.

Read More

Research Domain Criteria -- RDoC

By Thomas Insel on

The RDoC project is an experimental approach to classification of mental disorders that will serve as a framework for ongoing research.

Read More

Spotlight on Eating Disorders

By Thomas Insel on

National Eating Disorders Awareness Week starts February 26. Dr. Insel discusses some surprising facts about these disorders, which are among the most fatal.

Read More

An Emerging Era of Big Data

By Thomas Insel on

Dr. Insel discusses the emergence of “big data” and how open sharing of data could impact mental health research.

Read More

The Long Paths to Breakthroughs

By Thomas Insel on

Dr. Insel talks about how basic research can lead to potential treatments.

Read More

Balancing Immediate Needs with Future Innovation

By Thomas Insel on

Dr. Insel responds to discussion from the National Advisory Mental Health Council concerning the need to balance research funding for basic science and mental health services.

Read More

We Are the Government

By Thomas Insel on

NIMH’s “government bureaucrats” are really dedicated public servants devoted to good patient care, improved  treatments, and scientific discovery.

Read More

Treatment Development: Where do we go from here?

By Thomas Insel on

Dr. Insel discusses opportunities for treatment development.

Read More